π Transition to Adult Care β Key elementsβ Start planning by age 14-16 | β Portable medical summary (diagnosis, surgeries, medications, allergies) | β Identify adult congenital heart disease (ACHD) specialist | β Discuss contraception, pregnancy risks, insurance, lifestyle | β Screen for depression, anxiety, adherence | β Use HEADSS assessment for adolescents.
π ACHD β High-risk conditionsβ Fontan circulation | β Systemic right ventricle (TGA after atrial switch) | β Pulmonary arterial hypertension (Eisenmenger) | β Severe aortic stenosis/coarctation with aneurysm | β Mechanical valve on anticoagulation | β Cyanotic CHD with residual defects.
π Supraventricular Tachycardia (SVT) β Mechanismsβ AVRT (accessory pathway β Wolff-Parkinson-White) β most common in infants | β AVNRT (dual AV node physiology) β common in adolescents | β Atrial flutter (intra-atrial reentry) β post-op CHD | β Atrial ectopic tachycardia (automatic) β often incessant.
π SVT β ECG featuresβ Narrow QRS (<0.09 sec) regular tachycardia | β Rate: newborns >220 bpm, children >180 bpm | β P waves: retrograde (inverted in II, III, aVF) or absent | β Sudden onset/termination | β WPW: delta wave, short PR in sinus rhythm.
π Acute SVT management β ABCDEβ Vagal maneuvers (ice to face in infants, Valsalva in older) | β Adenosine 0.1 mg/kg rapid IV push (max 6 mg) β repeat 0.2 mg/kg (max 12 mg) | β Synchronized cardioversion if unstable (0.5-1 J/kg) | β Esophageal overdrive pacing if available.
π Long-term SVT treatmentβ Beta-blockers (propranolol, nadolol) first-line | β Digoxin (avoid in WPW) | β Flecainide, propafenone, sotalol or amiodarone for refractory | β Catheter ablation (curative) β especially AVRT, AVNRT, atrial flutter | β Infant SVT often resolves by 12-18 months.
π WPW β risk stratificationβ Syncope + WPW = high risk | β Intermittent preexcitation does not exclude risk | β Invasive EP study for high-risk athletes/symptomatic | β Ablation for high-risk accessory pathways (short refractory period).
π Transition: Transfer of Care Checklistβ Transfer summary by age 18 | β Adult provider introduction | β Establish self-management skills (medication, appointments, insurance) | β Discuss reproductive health (contraindicated pregnancy conditions: PAH, severe ventricular dysfunction, Fontan complications).
1οΈβ£ Immediate (unstable patient) βͺ Synchronized cardioversion: 0.5-1 J/kg, repeat 2 J/kg. βͺ If IV access: adenosine while preparing cardioversion. βͺ Prepare for intubation/resuscitation if deteriorated.
2οΈβ£ Stable patient β Vagal maneuvers βͺ Infant: ice bag to face (covering eyes and nose) for 15-30 sec. βͺ Child/adolescent: Valsalva (blow through syringe, strain), modified Valsalva (supine to leg raise), carotid massage (avoid in children). βͺ No ocular pressure.
3οΈβ£ Pharmacologic (stable) βͺ Adenosine: 0.1 mg/kg rapid IV push (max 6 mg) followed by saline flush; if no effect β 0.2 mg/kg (max 12 mg). βͺ Second-line: esmolol (IV), procainamide, amiodarone (only if refractory).
4οΈβ£ Post-conversion management βͺ ECG documentation, echocardiogram to exclude structural disease. βͺ Start oral propranolol (1-2 mg/kg/day) or nadolol. βͺ Avoid digoxin/verapamil if WPW (risk of VF). βͺ Refer to pediatric cardiology for long-term plan (ablation vs medication).
5οΈβ£ Long-term & Transition (CHD patients) βͺ For ACHD with residual arrhythmia: ablation, risk of recurrence. βͺ Transition planning: transfer of care summary, adult EP consult. βͺ Pregnancy counseling for women with SVT/WPW.
β Reflex prompt 1: A 2-week-old with heart rate 280 bpm, pale, poor feeding. What is your immediate action? β Answer: Unstable β synchronized cardioversion 0.5-1 J/kg. If IV in place, adenosine first while preparing cardioverter.
β Reflex prompt 2: A 12-year-old with recurrent palpitations, ECG shows delta wave and short PR. Which medications are contraindicated? β Answer: Digoxin and verapamil (calcium channel blockers) β can accelerate antegrade conduction over accessory pathway β VF risk. Use beta-blockers or refer for ablation.
β Reflex prompt 3: A 16-year-old with repaired tetralogy of Fallot presents with irregular tachycardia, ECG shows sawtooth flutter. Most likely arrhythmia? β Answer: Atrial flutter (intra-atrial reentry). Common after atrial surgery. Needs anticoagulation before cardioversion (if >48hr) and may respond to class III agents or ablation.
β Reflex prompt 4: What are the essential components of a transition readiness plan for a 17-year-old with Fontan circulation? β Answer: Portable medical summary, cardiac diagnosis & surgeries, list of medications, allergy, identify adult CHD specialist, discuss contraception (avoid OCPs), pregnancy risk (high risk), psychosocial assessment, insurance transfer, and self-management skills.
β Reflex prompt 5: Infant SVT: what is the success rate of adenosine? When would you use esophageal pacing? β Answer: Adenosine success >90%. Esophageal pacing used when adenosine contraindicated (asthma, severe bronchospasm) or to differentiate from atrial flutter.
π Chapter 152 β Transitioning to Adult Care (Nelson 22e)
β’ Goal: Prepare youth with chronic conditions (CHD, cardiomyopathy) for adult healthcare. Start by age 14-16.
β’ Key elements: Portable medical summary (diagnosis, surgeries, medications, allergies, last echo), transition readiness assessment, transfer of care to ACHD specialist.
β’ High-risk conditions for pregnancy: Pulmonary hypertension, Fontan with complications, systemic RV dysfunction, severe aortic stenosis, Marfan with aorta >45mm. Contraindicated pregnancy.
β’ Psychosocial: Screen for depression, anxiety, adherence, substance use (HEADSS). Promote self-advocacy.
π Chapter 484.3 β Supraventricular Tachycardia (SVT)
β’ Mechanisms: AVRT (WPW β accessory pathway) most common in infants; AVNRT (dual AV node) adolescents; atrial flutter post-surgery CHD.
β’ Diagnosis: Narrow QRS tachycardia, rate >220 (infants) / >180 (children), sudden onset/offset. Differentiate from sinus tachycardia (gradual, variable).
β’ Acute treatment: Unstable β synchronized cardioversion (0.5-1 J/kg). Stable β vagal maneuvers (ice to face, Valsalva), adenosine 0.1-0.2 mg/kg IV push.
β’ Chronic management: Beta-blockers first-line (propranolol, nadolol). Avoid digoxin/verapamil in WPW. Catheter ablation curative (especially AVRT/AVNRT).
β’ WPW risk: Syncope, rapid conduction during atrial fibrillation, family history sudden death β EP study and ablation.
β’ Transition relevance: Patients with CHD and SVT need lifelong EP follow-up, pregnancy risk assessment, and planning for ablation in specialized ACHD centers.
π‘ Clinical Pearl: In infants, SVT often presents with heart failure after 24h; suspect if unexplained poor feeding/irritability. Adenosine is safe and first-line in stable infants.